Sequencing stimulant

Leapfrogging is the name of the game in the supplier space, even if new tools cannibalize one's own products. Thus Applied Biosystems Group hopes its $120 million acquisition of Agencourt Personal Genomics will give it a competitive position in next-generation nucleic acid analysis products, even though Agencourt's technology could end up replacing ABI's Capillary Electrophoresis (CE) DNA Analyzers.

Agencourt (Beverly, Mass.) is developing a massively parallel process that can sequence an entire genome simultaneously...